Wilmington Savings Fund Society’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.4K Sell
689
-223
-24% -$14.9K ﹤0.01% 910
2026
Q1
$57.3K Sell
912
-209
-19% -$14.6K ﹤0.01% 850
2025
Q4
$74.4K Sell
1,121
-25
-2% -$1.62K ﹤0.01% 801
2025
Q3
$77.1K Sell
1,146
-3,711
-76% -$294K ﹤0.01% 796
2025
Q2
$424K Sell
4,857
-4,739
-49% -$371K 0.01% 622
2025
Q1
$655K Buy
9,596
+4,810
+101% +$393K 0.01% 517
2024
Q4
$372K Sell
4,786
-899
-16% -$66.6K 0.01% 657
2024
Q3
$381K Buy
+5,685
New +$467K 0.01% 641

Other funds holding DXCM

Wilmington Savings Fund Society's DXCM Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its DexCom (DXCM) stake by 24% in Q2 2026, selling an estimated $14.9K and leaving 689 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #910.

Wilmington Savings Fund Society first reported a position in DXCM in Q3 2024 and has held it in 8 quarters since. The position peaked at $655K in Q1 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Wilmington Savings Fund Society held 689 shares of DexCom worth $46.4K as of Q2 2026.
  • Wilmington Savings Fund Society sold 223 DexCom shares in Q2 2026, an estimated $14.9K.
  • DexCom made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #910 holding.
  • Wilmington Savings Fund Society first reported a position in DexCom in Q3 2024 and has held it in 8 quarters since.
  • Wilmington Savings Fund Society's DexCom position peaked at $655K in Q1 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.